Efferent Lymphaticovenular Anastomosis for Pelvic and Lower Extremity Lymphedema after Gynecologic Cancer Treatment: Indication and Timing Criteria Based on Nodal Function

Abstract

Background

Efferent lymphaticovenular anastomosis (ELVA) uses efferent lymphatic vessels from inguinal lymph nodes, which receive multiple afferent inputs from the lower extremity, to drain substantial lymphatic fluid. However, nodal degeneration during disease progression may impair function and affect ELVA efficacy. This study evaluated ELVA outcomes for lower extremity and pelvic lymphedema based on the presence or absence of nodal degeneration.

Methods

This retrospective study included 30 patients who underwent LVA using the ELVA technique for pelvic and lower extremity lymphedema (LEL) following gynecological cancer treatment. Preoperative ultrasonography was performed to assess the vascularity of the inguinal lymph nodes. Patients with preserved nodal vascularity were classified into the primary ELVA group and underwent ELVA as the initial treatment. Those without detectable vascular flow were initially treated with leg LVA; ELVA was subsequently performed once the vascularity of the inguinal nodes improved. Treatment efficacy was evaluated based on changes in pelvic and leg volume indices.

Results

Based on preoperative ultrasonography, seven patients were classified into the primary ELVA group and 23 into the secondary ELVA group. Preoperative ICG lymphography revealed significantly lower severity in the primary group (p < 0.01). The mean postoperative follow-up period was 31.5 months. Significant volume reductions were observed in leg and pelvic regions, with LEL index reduced from 275.1 ± 33.8 to 247.8 ± 28.2 (p < 0.01), and pelvic lymphedema index from 1,053.2 ± 81.2 to 972.7 ± 76.5 (p < 0.01). No significant differences in volume reduction were found between the two groups.

Conclusion

ELVA may be effective for both pelvic and LEL, even in advanced cases when performed after nodal function recovery.

Keywords

ELVA - lymph node - lymphedema

Publikationsverlauf

Eingereicht: 11. Juni 2025

Angenommen: 21. September 2025

Accepted Manuscript online:
09. Oktober 2025

Artikel online veröffentlicht:
30. Oktober 2025

• References

• 1 Rockson SG, Keeley V, Kilbreath S, Szuba A, Towers A. Cancer-associated secondary lymphoedema. Nat Rev Dis Primers 2019; 5 (01) 22
• 2 Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer 2007; 109 (12) 2607-2614
• 3 Biglia N, Librino A, Ottino MC, Panuccio E, Daniele A, Chahin A. Lower limb lymphedema and neurological complications after lymphadenectomy for gynecological cancer. Int J Gynecol Cancer 2015; 25 (03) 521-525
• 4 Yamamoto T, Yamamoto N, Yoshimatsu H, Narushima M, Koshima I. Factors associated with lymphosclerosis: an analysis on 962 lymphatic vessels. Plast Reconstr Surg 2017; 140 (04) 734-741
• 5 Mihara M, Hara H, Kawasaki Y. et al. Lymphatic venous anastomosis and complex decongestive therapy for lymphoedema: randomized clinical trial. Br J Surg 2024; 111 (01) znad372
• 6 Scaglioni MF, Fontein DBY, Arvanitakis M, Giovanoli P. Systematic review of lymphovenous anastomosis (LVA) for the treatment of lymphedema. Microsurgery 2017; 37 (08) 947-953
• 7 Seki Y, Kajikawa A, Yamamoto T, Takeuchi T, Terashima T, Kurogi N. Single lymphaticovenular anastomosis for early-stage lower extremity lymphedema treated by the superior-edge-of-the-knee incision method. Plast Reconstr Surg Glob Open 2018; 6 (02) e1679
• 8 Seki Y, Okino T, Nemoto H. et al. Lymphaticovenular anastomosis as a treatment for neurogenic bladder in patients with lower extremity lymphedema after gynecologic cancer treatment. J Surg Oncol 2025; 131 (01) 77-83
• 9 Yang JC, Wu SC, Lin WC, Chiang MH, Chiang PL, Hsieh CH. Supermicrosurgical lymphaticovenous anastomosis as alternative treatment option for moderate-to-severe lower limb lymphedema. J Am Coll Surg 2020; 230 (02) 216-227
• 10 Visconti G, Hayashi A, Bianchi A, Tartaglione G, Bartoletti R, Salgarello M. Lymphaticovenular anastomosis for advanced-stage peripheral lymphedema: expanding indication and introducing the hand/foot sign. J Plast Reconstr Aesthet Surg 2022; 75 (07) 2153-2163
• 11 Yamamoto T, Yamamoto N, Yamashita M, Furuya M, Hayashi A, Koshima I. Efferent lymphatic vessel anastomosis: supermicrosurgical efferent lymphatic vessel-to-venous anastomosis for the prophylactic treatment of subclinical lymphedema. Ann Plast Surg 2016; 76 (04) 424-427
• 12 Akita S, Yamaji Y, Kuriyama M. et al. Intraoperative detection of efferent lymphatic vessels emerging from lymph node during lymphatic microsurgery. J Reconstr Microsurg 2019; 35 (05) 372-378
• 13 Akita S, Yamaji Y, Tokumoto H. et al. Improvement of the efficacy of vascularized lymph node transfer via a prefabricated lympho-venous shunt through lymphaticovenular anastomosis. Microsurgery 2018; 38 (03) 270-277
• 14 Gentileschi S, Albanese R, Pino V. et al. SPECT/CT and fusion ultrasound to target the efferent groin lymph node for lymphatic surgery. Microsurgery 2019; 39 (07) 605-612
• 15 Bjørnholt SM, Groenvold M, Petersen MA. et al. Patient-reported lymphedema after sentinel lymph node mapping in women with low-grade endometrial cancer. Am J Obstet Gynecol 2025; 232 (03) 306.e1-306.e11
• 16 Kuroda K, Yamamoto Y, Yanagisawa M. et al. Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study. BMC Womens Health 2017; 17 (01) 50
• 17 Akita S, Mitsukawa N, Rikihisa N. et al. Early diagnosis and risk factors for lymphedema following lymph node dissection for gynecologic cancer. Plast Reconstr Surg 2013; 131 (02) 283-290
• 18 Jung SG, Im SH, Kim M. et al. The association between the number of retrieved pelvic lymph nodes and ipsilateral lower limb lymphedema. J Invest Surg 2022; 35 (05) 978-983
• 19 Yamamoto T, Matsuda N, Doi K. et al. The earliest finding of indocyanine green lymphography in asymptomatic limbs: the modified dermal backflow stage and subclinical lymphedema. Plast Reconstr Surg 2011; 128 (04) 314e-321e
• 20 Akita S, Mitsukawa N, Kuriyama M. et al. Suitable therapy options for sub-clinical and early-stage lymphoedema patients. J Plast Reconstr Aesthet Surg 2014; 67 (04) 520-525
• 21 Alshomer F, Jeong HH, Pak CJ, Suh HP, Hong JP. Identifying functional lymph nodes in lower extremity lymphedema patients: the role of high-frequency ultrasound. J Reconstr Microsurg 2024; 40 (07) 527-534
• 22 Seki Y, Yamamoto T, Yoshimatsu H. et al. The superior-edge-of-the-knee incision method in lymphaticovenular anastomosis for lower extremity lymphedema. Plast Reconstr Surg 2015; 136 (05) 665e-675e
• 23 Yamamoto T, Yamamoto N, Hayashi N, Hayashi A, Koshima I. Practicality of the lower extremity lymphedema index: lymphedema index versus volumetry-based evaluations for body-type-corrected lower extremity volume evaluation. Ann Plast Surg 2016; 77 (01) 115-118
• 24 Imai H, Kawase T, Yoshida S. et al. Peripheral T cell profiling reveals downregulated exhaustion marker and increased diversity in lymphedema post-lymphatic venous anastomosis. iScience 2023; 26 (06) 106822
• 25 Mihara M, Hara H, Zhou HP, Tange S, Kikuchi K. Lymphaticovenous anastomosis releases the lower extremity lymphedema-associated pain. Plast Reconstr Surg Glob Open 2017; 5 (01) e1205
• 26 Thomas M, Pike C, Humphreys I, Bragg T, Ghattaura A. Impact and outcomes after lymphaticovenous anastomosis for 150 cases of lymphoedema followed up over 24 months. J Plast Reconstr Aesthet Surg 2023; 85: 104-113
• 27 Yang JC, Wu SC, Wang YM. et al. Effect of lymphaticovenous anastomosis on muscle edema, limb, and subfascial volume in lower limb lymphedema: MRI studies. J Am Coll Surg 2022; 235 (02) 227-239
• 28 International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. 2009 Concensus Document of the International Society of Lymphology. Lymphology 2009; 42 (02) 51-60